Cour Pharma
2 known investors
COUR develops targeted therapies for autoimmune diseases using an antigen-specific platform technology designed to restore immune tolerance while preserving normal immune function. The company focuses on disease-modifying treatments for immune-mediated conditions.
BiotechHealthtechMedical Devices